Knome's Launch Topped Most-Read GenomeWeb Daily News Stories Last Week

Dec 03, 2007

Knome’s Launch Topped Most-Read GenomeWeb Daily News Stories Last Week

NEW YORK (GenomeWeb News) - What are GenomeWeb News subscribers reading? Below are the five most-read articles for the five-day period ended Friday, Nov. 30.

1. Startup Offers Comprehensive Personalized Genome Sequencing For a Hefty Price (from Nov. 29)

2. Core Labs' Embrace of Next-Gen Sequencers Surprises Some (from Nov. 26)

3. Beckman Coulter to Buy Remainder of NexGen (from Nov. 29)

4. Gates Foundation Awards Md. Vaccine Center $5.6M for Pathogen Dx; Illumina, Ibis Tapped as Subcontractors (from Nov. 28)

5. Sorensen's Retail Paternity Test Designed for 'Peace of Mind' (from Nov. 30)

Breaking News

The Scan

Study Reveals Details of SARS-CoV-2 Spread Across Brazil

A genomic analysis in Nature Microbiology explores how SARS-CoV-2 spread into, across, and from Brazil.

New Study Highlights Utility of Mutation Testing in Anaplastic Thyroid Cancer

Genetic mutations in BRAF and RAS are associated with patient outcomes in anaplastic thyroid carcinoma, a new JCO Precision Oncology study reports.

Study Points to Increased Risk of Dangerous Blood Clots in COVID-19 Patients

An analysis in JAMA Internal Medicine finds that even mild COVID-19 increases risk of venous thromboembolism.

Y Chromosome Study Reveals Details on Timing of Human Settlement in Americas

A Y chromosome-based analysis suggests South America may have first been settled more than 18,000 years ago, according to a new PLOS One study.

Knome's Launch Topped Most-Read GenomeWeb Daily News Stories Last Week

Retinoblastoma Study Reveals Pathogenesis Gene Downstream of Mutated RB1

New Products Posted to GenomeWeb: Qiagen, Boston Heart Diagnostics, Bio-Techne, More

People in the News at 23andMe, PerkinElmer, Capsulomics, More

In Brief This Week: Applied DNA Sciences, LumiraDx, Lucid Diagnostics, Nanomix, Strata Oncology

High-Throughput Testing Reveals Genetic Programs, Pathogenic Variants in Neurodegenerative Disease

Study Reveals Details of SARS-CoV-2 Spread Across Brazil

New Study Highlights Utility of Mutation Testing in Anaplastic Thyroid Cancer

Study Points to Increased Risk of Dangerous Blood Clots in COVID-19 Patients

Y Chromosome Study Reveals Details on Timing of Human Settlement in Americas

UPDATE: Genapsys Founders Lose Bid to Dismiss Bankruptcy Case

Cancer Centers Nudge Oncologists Toward DPYD Testing as PGx Supporters Push For Guidelines Change
Premium

Polygenic Risk Scores Can Differ for Same Disease in Individuals, Hampering Clinical Implementation
Premium

Sema4 Cuts 13 Percent of Workforce, Exits Somatic Tumor Testing as Founder Schadt Departs
Premium

Eurobio Scientific to Acquire GenDx for €135M in Cash

Knome's Launch Topped Most-Read GenomeWeb Daily News Stories Last Week

Cancer Centers Nudge Oncologists Toward DPYD Testing as PGx Supporters Push For Guidelines Change Premium

Polygenic Risk Scores Can Differ for Same Disease in Individuals, Hampering Clinical Implementation Premium

Sema4 Cuts 13 Percent of Workforce, Exits Somatic Tumor Testing as Founder Schadt Departs Premium

Cancer Centers Nudge Oncologists Toward DPYD Testing as PGx Supporters Push For Guidelines Change
Premium

Polygenic Risk Scores Can Differ for Same Disease in Individuals, Hampering Clinical Implementation
Premium

Sema4 Cuts 13 Percent of Workforce, Exits Somatic Tumor Testing as Founder Schadt Departs
Premium